Israel’s DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
Read more on Reuters here.
![[Foretellix in Calcalist] “We have the most critical ingredient to make autonomous systems safe and efficient.”](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Foretellix in Calcalist] “We have the most critical ingredient to make autonomous systems safe and efficient.”
February 15, 2022
[Classiq in News Direct] Classiq and Oxford Quantum Circuits partner to advance seamless quantum computing and data center convergence
December 5, 2023
